Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3049928 | Epilepsy & Behavior | 2012 | 7 Pages |
This study evaluated the resource use of patients with epilepsy in the German district of Marburg-Biedenkopf. A cross-sectional cohort of consecutive adults with epilepsy, irrespective of seizure severity, duration of illness and epilepsy syndrome, was investigated in all health-care sectors. Costs of inpatient and outpatient treatment were derived from billing data of participating hospitals and office-based physicians. Data on socioeconomic status, course of epilepsy and further direct and indirect costs were recorded using patient questionnaires.We enrolled 366 patients from the district of Marburg-Biedenkopf and calculated annual epilepsy-specific costs of €7738 per patient. Direct costs contributed 31.1% (€2406) and indirect costs 68.9% (€5332) of the total costs. Direct medical costs were mainly due to hospitalization (33.2% of total direct costs) and anticonvulsants (26.7%). Costs of admissions were due to status epilepticus (24.4%), video-EEG monitoring (14.8%), newly diagnosed patients (14.4%) and seizure-related injuries (8.8%). Indirect costs were mainly due to early retirement (38.0%), unemployment (35.9%) and days off due to seizures (26.2%). The mean costs of epilepsy found in our study were lower than those found in studies conducted at European epilepsy centers due to the inclusion of patients in all health-care sectors.
► Epilepsy causes considerable use of health-care resources and loss of productivity. ► We evaluated costs of epilepsy patients in the German district of Marburg-Biedenkopf. ► Annual epilepsy-specific costs were estimated at €7.738 per patient. ► Direct costs contributed 31.1% and indirect costs 68.9% of the total costs. ► Early retirement as main cost factor may be preventable by therapeutic interventions.